Advertisement

Role of multidimensional assessment of frailty in predicting short-term outcomes in hospitalized cancer patients: results of a prospective cohort study

Abstract

Aims and background. The study analyzed the value of physical and psychosocial frailty assessment in predicting the need for supportive care and the risk of shortterm failures after discharge in hospitalized cancer patients.
Methods and study design. Frailty was assessed in 350 consecutive patients using a multidimensional tool. Patients were followed for 4 months after discharge to record the occurrence of chemotherapy interruption, urgent hospital readmission or death. The association between patient characteristics and the outcomes were analyzed with either logistic or Cox multivariable models.
Results. About 40% of patients were classified as frail, with a higher prevalence of clinical frailty (alone or together with psychosocial frailty). Psychosocial frailty was positively associated with the need for supportive care at discharge (adjusted OR, 3.46; 95% CI, 1.55-7.76) but did not predict a worse prognosis when other important clinical factors were considered. However, the need for supportive care at discharge, in addition to advanced disease and reduced performance status, was a strong predictor of short-term hospital readmission or death (HR 7.50; 95% CI, 3.12-18.02).
Conclusions. A more comprehensive assessment of frailty in cancer patients can aid in the timely identification of the need for supportive care after hospital discharge and improves the prediction of the short-term risk of hospital readmission or death.

Tumori 2014; 100(1): 91 - 96

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1430.15822

Authors

Agostino Ponzetti, Patrizia Lista, Eva Pagano, Maria Maddalena Demichelis, Libero Ciuffreda, Giovannino Ciccone

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Ponzetti, Agostino [PubMed] [Google Scholar]
    Unit of Medical Oncology 1, San Giovanni Battista hospital “Città della Salute e della Scienza”, Turin, Italy
  • Lista, Patrizia [PubMed] [Google Scholar]
    Unit of Medical Oncology 1, San Giovanni Battista hospital “Città della Salute e della Scienza”, Turin, Italy
  • Pagano, Eva [PubMed] [Google Scholar]
    Unit of Cancer Epidemiology, San Giovanni Battista hospital “Città della Salute e della Scienza”, Turin, Italy
  • Demichelis, Maria Maddalena [PubMed] [Google Scholar]
    Unit of Medical Oncology 1, San Giovanni Battista hospital “Città della Salute e della Scienza”, Turin, Italy
  • Ciuffreda, Libero [PubMed] [Google Scholar]
    Unit of Medical Oncology 1, San Giovanni Battista hospital “Città della Salute e della Scienza”, Turin, Italy
  • Ciccone, Giovannino [PubMed] [Google Scholar]
    Unit of Cancer Epidemiology, San Giovanni Battista hospital “Città della Salute e della Scienza”, Turin, Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.